Sharda Cropchem soars to a record high, up 20% on robust Q3 earnings

EBITDA margin expanded by 220 bps YoY to 22.8 per cent in Q3FY22 driven by economies of scale, effective cost management marginally settled off by higher freight cost.

fertilisers
Finished DAP imported prices are expected to remain high because of this.
SI Reporter Mumbai
2 min read Last Updated : Jan 24 2022 | 10:59 AM IST
Shares of Sharda Cropchem rallied 20 per cent, and in the process hit a new all-time high of Rs 454.70, in Monday’s intra-day trade in an otherwise weak market on the back of robust Q3 numbers. The company's Q3 net profit more-than-doubled to Rs 102 crore in December quarter (Q3FY22). The agrochemicals company had posted PAT of Rs 48.3 crore in a year ago quarter.

The company’s revenue grew by 78.2 per cent YoY to Rs 879.8 crore in Q3FY22 led by strong volume growth across geographies & better product mix & price realisation. Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin expanded by 220 bps YoY to 22.8 per cent in Q3 FY22 driven by economies of scale, effective cost management marginally settled off by higher freight cost.

The company’s board declared an interim dividend of Rs 3 per equity share for the financial year 2021-22. The company fixed February 2, 2022 as record date for the purpose of interim dividend. The interim dividend shall be paid or dispatched on or before March 01, 2022, the company said.

Anand Rathi Share and Stock Brokers has a ‘Buy’ rating on Sharda Cropchem with a target price of Rs 480 per share. “Powered by its focus on registering formulations and active ingredient across regions, Sharda’s strong growth would continue. A strong pipeline and distribution network would add to growth. Internally funded capex and FCF generation would strengthen its balance sheet, resulting in higher return ratios,” the brokerage firm said in its initiate coverage report dated December 30, 2021.

Its identification of off-patent high-demand molecules, high registration cost and a long gestation period in registering formulations and active ingredients are high entry barriers, the brokerage firm said.

At 10:30 am; the stock was up 15 per cent at Rs 436 on the BSE, as against a 1.1 per cent decline in the S&P BSE Sensex. The trading volume at the counter jumped three-fold with a combined 3.12 million equity shares changing hands on the NSE and BSE.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Buzzing stocksSharda CropchemMarket trendsQ3 results

Next Story